Global High-Priority Regulatory Events — December 17, 2025

18-12-2025

Dragonfly Energy Holdings Corp. filed an 8-K on 2025-12-18 disclosing Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and 9.01 (Financial Statements and Exhibits). No specific details on the modifications, amendments, or exhibits are provided in the summary. Analysis is limited; all quantitative data and event specifics are NOT_DISCLOSED.

• ·Multi-item 8-K filing covering governance changes (3.03, 5.03) and exhibits (9.01).
• ·Core event involves material modifications to security holder rights and corporate amendments; transaction value, share count, and financial metrics NOT_DISCLOSED.
• ·Filing timing and compliance cannot be assessed without full details; no revenue, balance sheet, or guidance impacts stated.

18-12-2025

Cartesian Growth Corp III filed a Form 8-K on December 18, 2025, reporting Items 1.01 (Entry into Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, or quantitative data are disclosed in the provided summary. Analysis is limited to filing structure; core event and impacts are NOT_DISCLOSED.

• ·Multi-item mandatory 8-K filing (Items 1.01, 3.02, 7.01, 9.01); filing date aligns with event but intra-day timing NOT_DISCLOSED.
• ·Core event involves material definitive agreement and unregistered equity sales; strategic importance and financial impacts NOT_DISCLOSED.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

18-12-2025

Treace Medical Concepts, Inc. filed a multi-item 8-K on December 18, 2025 (AccNo: 0001193125-25-323802), reporting entry into (Item 1.01) and termination of (Item 1.02) material definitive agreements, creation of a direct financial obligation (Item 2.03), material modifications to security holders' rights (Item 3.03), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and exhibits (Item 9.01). No specific transaction values, financial metrics, or details are disclosed in the provided summary. This indicates significant corporate developments, but analysis is limited without full filing content.

• ·Multi-item mandatory 8-K filing covering agreements, financial obligations, and security holder rights changes
• ·Filed on event date (2025-12-18), likely within 4-business-day requirement
• ·All quantitative data (transaction value, share count, percentages) NOT_DISCLOSED

18-12-2025

Plumas Bancorp filed a Form 8-K on December 18, 2025 (AccNo: 0001437749-25-038239), reporting entry into a Material Definitive Agreement under Item 1.01 and attaching Financial Statements and Exhibits under Item 9.01. This is a multi-item mandatory disclosure of a material event, but specific details of the agreement, transaction value, or financial impacts are NOT_DISCLOSED in the provided summary. Analysis is limited without full filing content.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing
• ·Core event: Entry into a Material Definitive Agreement (details NOT_DISCLOSED)
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED
• ·Timing and filing compliance details NOT_DISCLOSED

18-12-2025

Company filed an 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement under Item 1.01 and attaching Financial Statements and Exhibits under Item 9.01. No details on the agreement, transaction value, company name, or sector are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Event and filing date: December 18, 2025
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED

18-12-2025

Spire Inc filed an 8-K on 2025-12-18 reporting entry into a material definitive agreement (Item 1.01) that creates a direct financial obligation (Item 2.03), with financial statements and exhibits (Item 9.01). No specific details on the agreement, transaction size, or financial terms are disclosed in the provided summary. This is a multi-item mandatory filing with unknown implications due to lack of content.

• ·Reported Items: 1.01 (Material Definitive Agreement), 2.03 (Direct Financial Obligation), 9.01 (Exhibits)
• ·Multi-item 8-K filing; timing aligns with event date but business hour compliance NOT_DISCLOSED
• ·Core event involves a material agreement creating financial obligation; all quantitative data NOT_DISCLOSED

18-12-2025

CLOUDASTRUCTURE, INC. filed an 8-K on December 18, 2025, disclosing entry into a Material Definitive Agreement under Item 1.01 with exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are provided in the summary. Analysis is limited to reported items; all other data is NOT_DISCLOSED.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: Entry into undisclosed Material Definitive Agreement.
• ·No quantitative data (e.g., transaction value, share count, financial metrics) disclosed.

18-12-2025

UNITY BANCORP INC /NJ/ filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, individual name, appointment/resignation status, reason, or quantitative data such as transaction values, share counts, or financial metrics are provided in the filing summary. This appears to be a routine disclosure with limited information available for analysis.

• ·Item 5.02: Officer change event disclosed, but key details (position, name, reason) NOT_DISCLOSED
• ·Filed on 2025-12-18; AccNo: 0000920427-25-000085
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED
• ·Sector not specified

18-12-2025

Reliance Global Group, Inc. filed a Form 8-K on December 18, 2025, reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 9.01 discloses Financial Statements and Exhibits. No additional details, numerical values, or transaction specifics are provided in the filing summary.

• ·Items reported: 3.01 (delisting notice) and 9.01 (financials/exhibits)
• ·Multi-item mandatory 8-K filing on delisting event
• ·Core event: Notice of delisting or listing rule failure; all other metrics (value, impact, financials) NOT_DISCLOSED

18-12-2025

Inspirato Inc filed an 8-K on December 18, 2025, reporting entry into a new material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), with exhibits under Item 9.01. No specific details on the agreements, transaction values, or financial impacts are disclosed in the provided summary. This represents a multi-item filing with mixed implications pending further details.

• ·Multi-item 8-K: Items 1.01 (entry), 1.02 (termination), 9.01 (exhibits)
• ·Core event: Entry into and termination of material definitive agreements; all quantitative data (value, shares, metrics) NOT_DISCLOSED
• ·Compliance appears standard; no timing violations evident from date match, but details absent

18-12-2025

Arcus Biosciences, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001724521-25-000122), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. No specific details on the transaction nature, parties, terms, or dollar value are disclosed in the provided information. This multi-item filing signals a potentially significant corporate development with financial implications.

• ·Multi-item 8-K: Items 1.01 (Material Definitive Agreement) and 2.03 (Financial Obligation/Off-Balance Sheet Arrangement)
• ·Core event: Entry into material agreement creating financial obligation; all quantitative data NOT_DISCLOSED
• ·Timing and compliance details NOT_DISCLOSED; sector not specified

18-12-2025

Burke & Herbert Financial Services Corp. filed an 8-K on 2025-12-18 reporting Items 1.01 (Entry into Material Definitive Agreement), 5.03 (Amendments to Articles of Incorporation or Bylaws), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing indicates a significant event but lacks specific details on the agreement, amendments, or disclosures in the provided summary. Quantitative data such as transaction value, share count, or financial metrics are NOT_DISCLOSED.

• ·Multi-item 8-K: Items 1.01, 5.03, 7.01, 9.01 reported
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
• ·Timing: Filed on event date 2025-12-18; compliance with 4-business-day window cannot be confirmed without full filing

18-12-2025

Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on December 18, 2025, disclosing an Item 5.02 event related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements, but no specific details on positions, reasons, or individuals are provided in the summary. Quantitative data such as transaction values, share counts, or percentages are NOT_DISCLOSED. Analysis is limited by lack of filing content, resulting in neutral implications.

• ·Item 5.02 filing indicates officer/director change or compensatory arrangement, but key details (position, appointment/resignation, reason) NOT_DISCLOSED.
• ·Filed within SEC 8-K timeline (within 4 business days), compliant with disclosure requirements.
• ·No board meeting outcomes, financial metrics, or governance impacts specified.

18-12-2025

Vor Biopharma Inc. filed a multi-item Form 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), personnel changes and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and exhibits (Item 9.01). No specific transaction details, dollar values, or quantitative impacts are disclosed in the provided summary. Analysis is limited to item disclosures, indicating potential dilution and strategic shifts but lacking core event facts.

• ·Multi-item 8-K filing covering material agreement, equity sales, officer changes, and Reg FD disclosure.
• ·Mandatory items (1.01, 3.02, 5.02) suggest significant events; voluntary Reg FD (7.01).
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.

18-12-2025

NexMetals Mining Corp. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, along with other events (Item 8.01) and exhibits (Item 9.01). No specific details on the officer position, appointment/departure, reasons, or quantitative data are provided in the summary. This is a routine SEC disclosure with limited actionable information.

• ·Item 5.02 triggered: Indicates departure, election, or appointment of directors/officers, but specifics NOT_DISCLOSED.
• ·Items 8.01 and 9.01 included: Other events and exhibits mentioned, details NOT_DISCLOSED.
• ·Quantitative data (transaction value, share count, percentages, financial metrics): ALL NOT_DISCLOSED.

18-12-2025

Zoetis Inc. filed a multi-item Form 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 2.03), Regulation FD disclosure (Item 7.01), and exhibits (Item 9.01). No specific transaction details, dollar values, or quantitative impacts are provided in the summary. Analysis is constrained by lack of filing content, resulting in neutral sentiment pending full review.

• ·Multi-item 8-K filing: Items 1.01, 2.03, 3.02, 7.01, 9.01 – likely mandatory disclosures
• ·Core events involve material agreement, financial obligation, and equity sales – details NOT_DISCLOSED
• ·No quantitative data (e.g., transaction value, share count) or financial impacts specified

18-12-2025

Methode Electronics Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements). Item 9.01 references financial statements and exhibits, but specific details on position, appointment/resignation, reasons, or quantitative data are NOT_DISCLOSED. Analysis limited to filing metadata; no substantive facts on leadership impact available.

• ·Item 5.02 disclosure signals officer change (departure, election, appointment, or compensatory arrangement), but key details NOT_DISCLOSED.
• ·No quantitative data (transaction values, share counts, percentages, financial metrics) mentioned: all NOT_DISCLOSED.
• ·Sector not specified; critical information on position affected, timing, and reasons missing, limiting analysis quality.

18-12-2025

Drilling Tools International Corp filed an 8-K on 2025-12-18 disclosing an Item 5.02 event for officer changes (departure, election, appointment, or compensatory arrangements). No specific details on position affected, individual, reason, or quantitative data are provided in the summary. Analysis is limited; event appears routine without disclosed materiality.

• ·Item 5.02 filing indicates officer-related change but key details (position, appointment/resignation, reason) NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED
• ·Neutral governance signal pending full filing review

18-12-2025

Mission Produce, Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), with Regulation FD Disclosure in Item 7.01 and exhibits in Item 9.01. Specific details on the affected officer, position (e.g., CEO/CFO), appointment/resignation, reasons, or quantitative data are NOT_DISCLOSED. Analysis limited to filing structure; no facts on leadership impact, governance, or market signals available.

• ·Item 5.02 indicates officer-related change, but key position, type (appointment/resignation), reason, and timing NOT_DISCLOSED
• ·Items 7.01 and 9.01 suggest additional disclosure and exhibits, details NOT_DISCLOSED
• ·No quantitative data (transaction value, share count, percentages, financial metrics) extracted: all NOT_DISCLOSED

18-12-2025

Teledyne Technologies Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), along with Other Events (Item 8.01) and Financial Statements/Exhibits (Item 9.01). Specific details on the affected officer, position, appointment/resignation, reasons, or quantitative data are NOT_DISCLOSED. Filing appears timely per SEC requirements.

• ·Item 5.02 signals officer change event, but key position (e.g., CEO/CFO), type (appointment/resignation), and reason (e.g., retirement/performance) are NOT_DISCLOSED.
• ·No board composition impact, governance details, succession signals, or quantitative metrics (transaction value, share count, percentages) disclosed.
• ·Routine SEC disclosure; no evidence of board meeting outcomes, dividends, M&A, or compliance issues.

18-12-2025

Professional Diversity Network, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001437749-25-038280), reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits). No specific transaction details, values, or quantitative data are disclosed in the provided summary. Analysis limited to filing structure; full content review required for impact assessment.

• ·Multi-item mandatory 8-K filing: Items 1.01, 3.02, 9.01
• ·Core events involve material agreement and unregistered equity sales; all specifics (value, shares, terms) NOT_DISCLOSED
• ·No financial metrics, guidance changes, or related filings mentioned

18-12-2025

Cognition Therapeutics Inc filed an 8-K on December 18, 2025, reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 1.02 (Termination of a Material Definitive Agreement). No details on the agreements, transaction values, or financial impacts are disclosed in the provided summary. This mixed event signals contractual changes but lacks specifics for impact assessment.

• ·Multi-item 8-K filing: Items 1.01 and 1.02
• ·Core events: Entry into new MDA and termination of prior MDA
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED

18-12-2025

Golden Matrix Group, Inc. filed an 8-K on December 18, 2025, disclosing an event under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements) with exhibits under Item 9.01. Specific details on the officer position, nature of change (appointment/resignation), reasons, or quantitative data are NOT_DISCLOSED. This is a routine SEC disclosure with no explicit facts on impact.

• ·Item 5.02 filing signals officer-related change or comp arrangement, but key details (position, internal/external, reason) NOT_DISCLOSED
• ·Filed timely (within 4 business days per SEC rules)
• ·No quantitative data (transaction value, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED
• ·Sector NOT_DISCLOSED; no board composition or governance specifics provided

18-12-2025

21Shares Solana ETF filed a Form 8-K on December 18, 2025 (AccNo: 0001213900-25-123314), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, or quantitative impacts disclosed in the summary. Analysis limited to reported items; full filing review recommended.

• ·Multi-item 8-K: Items 1.01, 8.01, 9.01
• ·Core event: Entry into Material Definitive Agreement (Item 1.01)
• ·Mandatory disclosure under SEC rules; timing compliance unknown without event date
• ·No transaction value, financial metrics, or other quantitative data disclosed

18-12-2025

Integrated Wellness Acquisition Corp, a SPAC, filed an 8-K on December 18, 2025, announcing a Merger/Acquisition via Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific deal details such as parties, structure, valuation, or financial metrics are disclosed in the provided filing summary. Analysis is limited to filing metadata, with all quantitative and qualitative deal terms NOT_DISCLOSED.

• ·8-K filing discloses merger/acquisition event under Items 7.01 and 9.01.
• ·AccNo: 0001104659-25-122565, filed 2025-12-18, file size 244 KB.
• ·Sector NOT_DISCLOSED; no parties, valuation, or structure specified.

18-12-2025

Rising Dragon Acquisition Corp. filed an 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01), submission of matters to a vote of security holders (Item 5.07), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on deal parties, structure, valuation, or quantitative metrics are disclosed in the filing summary. Analysis is limited to filing items with all key deal data marked as NOT_DISCLOSED.

• ·Item 1.01 indicates entry into a material definitive agreement, likely related to merger/acquisition.
• ·Item 5.07 reports submission of matters to shareholder vote.
• ·Items 8.01 and 9.01 cover other events and exhibits; sector NOT_DISCLOSED.

18-12-2025

Zynex Inc filed an 8-K on December 18, 2025, disclosing bankruptcy or receivership (Item 1.03), entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), and notice of delisting (Item 3.01). No specific details, dollar values, or financial metrics are provided in the filing summary. This represents a multi-item filing signaling severe financial distress.

• ·Multi-item 8-K filing: Items 1.01, 1.03, 2.03, 3.01, 9.01.
• ·Core event: Bankruptcy or receivership; material agreement and financial obligation creation.
• ·Delisting notice indicates failure to meet listing standards.

18-12-2025

Howard Hughes Holdings Inc. filed a Form 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction values, or impacts are disclosed in the provided summary. This is a multi-item filing likely mandatory for Items 1.01 and 3.02.

• ·Multi-item 8-K: Items 1.01 (material agreement), 3.02 (unregistered equity sales), 7.01 (Reg FD), 9.01 (exhibits)
• ·Core events involve material agreement and equity sales; quantitative details NOT_DISCLOSED
• ·Filing within same day of event date; compliance with 4-business-day window presumed but timing precision unknown

18-12-2025

Newton Golf Company, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, shareholder vote results under Item 5.07, and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or vote outcomes are provided in the summary. Quantitative data such as transaction values, share counts, or financial metrics: NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or appointment of directors/officers, but key position, type (appointment/resignation), reason, and timing: NOT_DISCLOSED.
• ·Item 5.07 reports shareholder vote matters, but outcomes, proposals (dividends, approvals, etc.): NOT_DISCLOSED.
• ·No board composition changes, governance implications, succession details, or regulatory compliance issues explicitly stated.

18-12-2025

Parsons Corp filed an 8-K on December 18, 2025, disclosing Item 5.02 regarding departure of directors/officers, elections, appointments, or compensatory arrangements. No specific details on positions, individuals, reasons, or quantitative data are provided in the summary. Analysis is severely limited by absence of filing content.

• ·Item 5.02 disclosure on officer/director changes or compensatory arrangements
• ·Event and filing date: December 18, 2025
• ·All specifics (positions, appointment/resignation, reasons, financials): NOT_DISCLOSED

18-12-2025

Scholastic Corp filed an 8-K on 2025-12-18 announcing completion of an acquisition or disposition of assets (Item 2.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03). Item 9.01 references financial statements and exhibits, but no specific deal details, parties, values, or terms are disclosed. Quantitative data extraction: Transaction Value NOT_DISCLOSED; Share Count NOT_DISCLOSED; Percentage Changes NOT_DISCLOSED; Financial Metrics NOT_DISCLOSED.

• ·Completion of unspecified acquisition/disposition of assets
• ·Creation of new direct financial obligation or off-balance sheet arrangement
• ·Exhibits filed but details NOT_DISCLOSED; critical info missing for full analysis

18-12-2025

Indivior PLC filed an 8-K on December 18, 2025, under Item 5.02 disclosing a departure, election, appointment of directors/officers, or compensatory arrangements. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit information.

• ·Item 5.02 filing indicates officer/director change event
• ·Filed timely: 2025-12-18 (AccNo: 0001625297-25-000076)
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED

18-12-2025

Korro Bio, Inc. filed an 8-K on 2025-12-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), with exhibits under Item 9.01. No specific details on position affected, appointment/resignation, reasons, or quantitative data are stated in the provided filing summary. All key facts such as names, roles, and impacts are NOT_DISCLOSED.

• ·Item 5.02 indicates officer-related change (departure, appointment, or compensatory arrangement), but specifics NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) mentioned: all NOT_DISCLOSED
• ·Routine SEC 8-K filing within required timeline; no board meeting outcomes or governance details provided

18-12-2025

VerifyMe, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001214659-25-018223), reporting under Item 3.01 a notice of delisting or failure to satisfy continued US exchange listing rules. This is a mandatory disclosure of a material negative event with no additional details on reasons, financial impacts, or transaction values provided. Delisting typically impairs liquidity and investor access.

• ·Single-item 8-K filing under Item 3.01 (Notice of Delisting or Failure to Satisfy Listing Rule)
• ·Event dated December 18, 2025; filed same day, likely within 4-business-day requirement
• ·No quantitative data (e.g., transaction value, share count: NOT_DISCLOSED); sector not specified

18-12-2025

ImageneBio, Inc. filed an 8-K on December 18, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements of certain officers. No specific details on the officer's position, name, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to absence of key facts from the filing.

• ·Item 5.02 filing indicates officer change but specifics (e.g., CEO/CFO, appointment/resignation, reasons) are NOT_DISCLOSED.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.
• ·Sector not specified; no board composition, governance, or market impact details available.

18-12-2025

21Shares Ethereum ETF filed Form 8-K on December 18, 2025 (AccNo: 0001213900-25-123294), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, or financial impacts are disclosed in the provided summary. This multi-item filing signals potentially material developments for the ETF, requiring review of the full 714 KB document.

• ·Multi-item 8-K: Items 1.01, 8.01, 9.01
• ·Core event: Entry into Material Definitive Agreement and Other Events
• ·All quantitative data (transaction value, shares, metrics): NOT_DISCLOSED

18-12-2025

Lumexa Imaging Holdings, Inc. filed an 8-K on 2025-12-18 reporting Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific transaction details, dollar values, or financial metrics provided in the summary. Analysis limited to disclosed items; full filing required for deeper insights.

• ·Multi-item 8-K: Items 1.01, 2.03, 9.01 reported
• ·Core event: Material definitive agreement and direct financial obligation (details NOT_DISCLOSED)
• ·No quantitative data (transaction value, share count, financial metrics: all NOT_DISCLOSED)

18-12-2025

Owens & Minor Inc/VA filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), alongside Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the summary. Analysis is limited to filing metadata, indicating a routine SEC disclosure without disclosed material impacts.

• ·Item 5.02 signals officer change (departure, election, appointment, or compensatory arrangements), but key details NOT_DISCLOSED.
• ·Includes Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01), suggesting potential additional context in attachments.
• ·No quantitative data (transaction values, share counts, percentages, financial metrics) or specifics on leadership role, timing, or reasons extracted; all NOT_DISCLOSED.

18-12-2025

LINKBANCORP, Inc. filed an 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. This is a multi-item filing indicating a significant event requiring public disclosure.

• ·Items reported: 1.01 (Material Definitive Agreement), 7.01 (Reg FD Disclosure), 9.01 (Exhibits)
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
• ·Quantitative data: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED

18-12-2025

Northpointe Bancshares Inc filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), with Item 9.01 listing exhibits. No specific details on positions, individuals, reasons, or quantitative data provided in the summary. Analysis limited to filing structure; all key facts NOT_DISCLOSED.

• ·Item 5.02 indicates officer departure, election, appointment, or compensatory arrangements
• ·Item 9.01 references financial statements and exhibits (Size: 174 KB)
• ·No names, positions, reasons, or numerical data explicitly stated

18-12-2025

Neuphoria Therapeutics Inc. filed an 8-K on December 18, 2025, reporting under Item 3.01 a notice of delisting or failure to satisfy continued listing rules from the US market. No additional details on reasons, financial impacts, or transaction values are disclosed in the provided filing summary. This event signals potential liquidity and visibility loss for shareholders.

• ·Single-item 8-K filing under Item 3.01 (Notice of Delisting or Failure to Satisfy Listing Rule).
• ·Core event: Delisting notice; all quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED.
• ·Sector not specified; no related filings, insider activity, or guidance changes mentioned.

18-12-2025

Ark 21Shares Bitcoin ETF filed an 8-K on December 18, 2025, reporting entry into a material definitive agreement under Item 1.01 and including financial statements/exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis limited to filing structure; critical event details NOT_DISCLOSED.

• ·8-K items: 1.01 (Material Definitive Agreement) and 9.01 (Exhibits); multi-item filing.
• ·Core event: Entry into undisclosed material agreement; all quantitative data (value, shares, metrics) NOT_DISCLOSED.
• ·Timing and compliance unknown; no revenue, balance sheet, or market reaction data available.

18-12-2025

Urban One, Inc. filed a Form 8-K on December 18, 2025, reporting multiple items including entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), changes in directors/officers or compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on transaction terms, values, or impacts are disclosed in the provided summary. This is a multi-item mandatory filing with unknown core event details.

• ·Multi-item 8-K filing covering material agreement, financial obligation, officer changes, and other events.
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.
• ·Timing compliance and strategic details NOT_DISCLOSED.

18-12-2025

Cartesian Therapeutics, Inc. filed an 8-K on December 18, 2025, disclosing an officer change (Item 5.02), amendment to Code of Ethics (Item 5.05), Regulation FD disclosure (Item 7.01), and exhibits (Item 9.01). No specific details on positions, reasons, or individuals provided. Quantitative data NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or appointment of officers/directors, but key position, type, and reason NOT_DISCLOSED.
• ·Item 5.05 reports Code of Ethics amendment or waiver, implications unclear without details.
• ·Items 7.01 and 9.01 suggest additional disclosure and exhibits, content NOT_DISCLOSED.

18-12-2025

ACV Auctions Inc. filed an 8-K on December 18, 2025 (AccNo: 0001637873-25-000025), reporting under Item 1.01 entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement's nature, value, or impacts are disclosed in the provided summary. This is a multi-item mandatory filing signaling a potentially significant event.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement), 9.01 (Exhibits)
• ·Multi-item 8-K filing; timing compliance NOT_DISCLOSED
• ·Core event: Material Definitive Agreement; all quantitative data (value, shares, metrics) NOT_DISCLOSED

18-12-2025

OneMain Holdings, Inc. filed a Form 8-K on 2025-12-18 reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). No specific transaction details, values, or impacts are disclosed in the provided summary. This is a multi-item mandatory filing.

• ·Multi-item 8-K: Items 1.01, 2.03, 9.01
• ·Core event: Material definitive agreement creating financial obligation
• ·No quantitative data (e.g., transaction value: NOT_DISCLOSED)

18-12-2025

Cars.com Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), alongside Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited to disclosure facts with all key change details NOT_DISCLOSED.

• ·Item 5.02 triggered for officer/director change event.
• ·Filed within SEC 8-K timeline (same day as event).
• ·No quantitative data (e.g., transaction values, shares, percentages) disclosed.

18-12-2025

SeaStar Medical Holding Corp filed an 8-K on December 18, 2025 (AccNo: 0001437749-25-038276), reporting under Items 3.03 (Material Modifications to Rights of Security Holders) and 5.07 (Submission of Matters to a Vote of Security Holders). No specific details on the modifications, vote outcomes, or quantitative impacts are disclosed. This is a multi-item mandatory disclosure likely related to shareholder meeting results.

• ·Items reported: 3.03 and 5.07 (multi-item filing)
• ·Core event: Material modifications to security holders' rights and matters submitted to shareholder vote
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED

18-12-2025

HOOKER FURNISHINGS Corp filed an 8-K on December 18, 2025, disclosing completion of an acquisition or disposition of assets under Item 2.01, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on parties, structure, valuation, or terms are provided in the filing summary. All quantitative data including transaction value, share count, and financial metrics are NOT_DISCLOSED.

• ·Item 2.01 confirms completion of acquisition or disposition of assets
• ·Item 8.01 covers other events (details NOT_DISCLOSED)
• ·Item 9.01 includes financial statements and exhibits (contents NOT_DISCLOSED)

18-12-2025

Phibro Animal Health Corp filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, along with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the summary. This is informational with no directional bias due to lack of explicit facts.

• ·Item 5.02: Disclosure of departure, election, or appointment of directors/officers.
• ·Item 7.01: Regulation FD disclosure included.
• ·No names, positions, reasons, or financial metrics disclosed.

18-12-2025

Lockheed Martin filed an 8-K on December 18, 2025, solely under Item 8.01 Other Events. No details on the event, transaction, financials, or impacts are disclosed in the provided summary. This limits analysis to procedural aspects only.

• ·Single-item filing: Item 8.01 Other Events
• ·Voluntary disclosure; no mandatory trigger specified
• ·No quantitative data or event description provided (all NOT_DISCLOSED)

18-12-2025

California Resources Corp filed an 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), along with other events (Item 8.01) and financial statements/exhibits (Item 9.01). No specific details on parties, deal structure, valuation, or financial metrics are disclosed in the provided filing summary. Analysis is limited to filing items and metadata; all quantitative data is NOT_DISCLOSED.

• ·Event involves merger/acquisition with completion reported under Item 2.01
• ·Material definitive agreement entered per Item 1.01
• ·Financial statements and exhibits included per Item 9.01; sector NOT_DISCLOSED

18-12-2025

Aether Holdings, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001493152-25-028360) under Item 5.02 disclosing an officer change. No specifics on the officer, position, appointment/resignation, reasons, or quantitative data are provided in the available summary. Analysis is severely limited by lack of filing details, resulting in neutral implications.

• ·Timely SEC 8-K filing under Item 5.02 for officer change.
• ·No details on key position (e.g., CEO/CFO), type (appointment/resignation), or reasons disclosed.
• ·Sector not specified; no quantitative data (shares, values, percentages) mentioned.

18-12-2025

Electromed, Inc. filed an 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits attached (Item 9.01). Specific transaction details, values, and impacts are NOT_DISCLOSED in the provided summary. This is a multi-item mandatory filing likely compliant with 4-business-day SEC timing.

• ·Multi-item 8-K filing: Items 1.01 (Material Definitive Agreement), 2.03 (Financial Obligation), 9.01 (Exhibits)
• ·Core event involves a material agreement creating financial obligations; dollar value, share count, and metrics NOT_DISCLOSED
• ·Voluntary/mandatory: Mandatory disclosure for material events; no quantitative financial impacts specified

18-12-2025

WhiteFiber, Inc. filed a Form 8-K on December 18, 2025 (AccNo: 0001213900-25-123321), reporting Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). Specific details on the agreement, transaction value, financial impacts, or strategic importance are NOT_DISCLOSED. Analysis is limited to filing structure due to lack of substantive content provided.

• ·Multi-item 8-K filing: Items 1.01, 7.01, 9.01
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
• ·No quantitative data (e.g., transaction value, share count: NOT_DISCLOSED); filing timing compliance unknown

18-12-2025

Beyond Meat, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, covering departures, elections, appointments, or compensatory arrangements of certain officers. No specific details on the affected position, individual, reason, or terms are provided in the filing summary. This is a routine SEC disclosure with no quantified financial or strategic impacts stated.

• ·Item 5.02: Officer change event (departure, appointment, or compensatory arrangements)
• ·Filed: 2025-12-18, AccNo: 0001655210-25-000220
• ·No names, positions, reasons, or numerical data disclosed

18-12-2025

Pangaea Logistics Solutions Ltd. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), along with Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). Specific details including officer names, positions affected, appointment/resignation status, or reasons are NOT_DISCLOSED. Analysis is limited by absence of filing content beyond item descriptions.

• ·Item 5.02 indicates officer or director change event
• ·Item 7.01 covers Regulation FD disclosure
• ·Item 9.01 lists financial statements and exhibits
• ·Filed timely on 2025-12-18 per SEC requirements; no quantitative data or specifics provided

18-12-2025

AIR T INC filed an 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), and creation of a direct financial obligation (Item 2.03). No specific details on parties, deal structure, valuation, or financial metrics are provided in the filing summary. Analysis is limited; all quantitative data is NOT_DISCLOSED.

• ·Completion of acquisition/disposition of assets reported under Item 2.01
• ·New material definitive agreement and financial obligation under Items 1.01 and 2.03
• ·Financial statements/exhibits referenced in Item 9.01, but content not detailed

18-12-2025

Berry Corp (BRY) 8-K filing on 2025-12-18 reports completion of an acquisition or disposition of assets (Item 2.01), termination of a prior material definitive agreement (Item 1.02), delisting notice (Item 3.01), change in control (Item 5.01), and related governance changes. No details on parties, deal structure, valuation, or consideration disclosed. All quantitative metrics (transaction value, shares, percentages) are NOT_DISCLOSED.

• ·Event signals deal completion with change in control and delisting, likely indicating acquisition of BRY or major asset sale.
• ·Governance shifts include director/officer changes (Item 5.02) and amendments to articles/bylaws (Item 5.03).
• ·Critical data missing: acquirer/target identities, value, consideration type (cash/stock), synergies, EPS impact.

18-12-2025

Intuitive Surgical Inc filed an 8-K on 2025-12-18 under Item 5.02, indicating a potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or quantitative data are explicitly stated in the provided filing summary. Analysis is constrained by lack of disclosed facts, resulting in neutral implications.

• ·Item 5.02 event: Generic disclosure on officer/director changes or compensatory arrangements; no names, positions (e.g., CEO/CFO), or reasons (e.g., retirement) specified.
• ·Quantitative data extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.
• ·No board meeting outcomes, succession details, or governance impacts detailed; critical information missing.

18-12-2025

Ondas Holdings Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers), along with other events in Item 8.01 and exhibits in Item 9.01. No specific details on the officer, position, appointment/resignation, or reasons are provided in the summary. Quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Item 5.02 indicates officer or director change, but key position (e.g., CEO/CFO) and nature (appointment/resignation) NOT_DISCLOSED.
• ·Items 8.01 and 9.01 suggest additional events and exhibits, details NOT_DISCLOSED.
• ·No board composition, succession, governance, or market impact details provided; analysis limited to filing structure.

18-12-2025

Ocugen, Inc. disclosed an officer change under Item 5.02 of Form 8-K filed on 2025-12-18, but key details including position affected, appointment/resignation status, reasons, and quantitative data are NOT_DISCLOSED. No facts on governance impact, succession, or market reaction provided. Analysis limited to filing metadata.

• ·Item 5.02: Departure/Election/Appointment of Officers or Directors; Compensatory Arrangements
• ·Filing Date: 2025-12-18 (AccNo: 0001104659-25-122610)
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED

18-12-2025

Quantum Corp filed a multi-item 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), and submission of matters to a shareholder vote (Item 5.07). No specific transaction details, values, or outcomes are disclosed in the provided summary. Analysis limited to item descriptions; full filing required for deeper insights.

• ·Multi-item 8-K filing covering material agreement, financial obligation, equity sales, and shareholder vote.
• ·Suggests potential transaction involving financing, dilution, and approvals; all quantitative data NOT_DISCLOSED.
• ·Filed as Material Event, indicating high regulatory significance but directional impact unclear.

18-12-2025

Nuburu, Inc. filed an 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), and unregistered sales of equity securities (Item 2.03). This is a multi-item mandatory filing with exhibits under Item 9.01; no specific transaction details, values, or terms are disclosed in the provided summary.

• ·Multi-item 8-K filing covering Items 1.01, 2.03, 3.02, and 9.01.
• ·Core event involves material agreement with financial obligation and equity sales; all quantitative data (e.g., transaction value, share count) NOT_DISCLOSED.
• ·Likely financing-related transaction; critical details missing, limiting impact assessment.

18-12-2025

Iron Horse Acquisition II Corp. filed an 8-K on December 18, 2025, announcing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on parties, deal structure, valuation, or quantitative metrics are disclosed in the provided filing summary. Analysis is limited; critical data such as transaction value, share counts, and financial impacts are NOT_DISCLOSED.

• ·8-K filing discloses material definitive agreement, suggesting merger/acquisition activity.
• ·Includes unregistered equity sales and governance amendments, typical for SPAC de-SPAC transactions.
• ·No quantitative data (e.g., deal value, exchange ratio) or strategic rationale provided.

18-12-2025

Webstar Technology Group Inc. disclosed the completion of an acquisition or disposition of assets via Item 2.01 in an 8-K filing on December 18, 2025 (AccNo: 0001493152-25-028379). No details on parties involved, deal structure, valuation, or strategic rationale are provided in the filing summary. Analysis is severely limited by absence of key quantitative and qualitative data.

• ·Event: Completion of Acquisition or Disposition of Assets (Item 2.01).
• ·Filing date: 2025-12-18; Sector: NOT_DISCLOSED.
• ·All transaction specifics (value, parties, consideration): NOT_DISCLOSED.

18-12-2025

Ulta Beauty, Inc. filed an 8-K on 2025-12-18 disclosing an officer change under Item 5.02 (Departure/Election of Officers or Compensatory Arrangements) and exhibits under Item 9.01. No details on officer name, position, appointment/resignation, reasons, or quantitative data are provided. Analysis limited to filing metadata.

• ·Item 5.02 indicates officer departure, election, appointment, or compensatory arrangement - specifics NOT_DISCLOSED.
• ·Timely SEC 8-K filing (within 4 business days requirement).
• ·No quantitative data (transaction values, shares, percentages, financial metrics: all NOT_DISCLOSED).

18-12-2025

Trump Media & Technology Group Corp. filed an 8-K on December 18, 2025, reporting under Items 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, transaction values, or financial impacts are disclosed in the provided summary. Analysis is limited to filing structure; core event details are NOT_DISCLOSED, precluding quantified assessment.

• ·Multi-item 8-K filing: Items 1.01, 8.01, and 9.01 reported.
• ·Item 1.01 indicates entry into a material definitive agreement (details NOT_DISCLOSED).
• ·Compliance with 4-business-day filing window cannot be assessed without event date.

18-12-2025

ADVENT CONVERTIBLE & INCOME FUND filed an 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01) and termination of a material definitive agreement (Item 1.02), with exhibits under Item 9.01. No details on the agreements, transaction values, or financial impacts are disclosed in the provided summary. This is a multi-item filing with unknown specifics.

• ·Reported Items: 1.01 (Entry into Material Definitive Agreement), 1.02 (Termination of Material Definitive Agreement), 9.01 (Financial Statements and Exhibits)
• ·Multi-item mandatory 8-K filing; timing compliance unknown
• ·Core event: Entry and termination of material agreements; all quantitative data NOT_DISCLOSED

18-12-2025

Bluerock Acquisition Corp. filed an 8-K on 2025-12-18 (AccNo: 0001213900-25-123337) under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) related to a Merger/Acquisition event. No specific deal structure, parties, valuation, quantitative metrics, or strategic details are explicitly stated in the provided filing summary. All key data such as transaction value, share counts, percentages, and financial metrics are NOT_DISCLOSED.

• ·Event: Merger/Acquisition announced via Item 8.01 Other Events
• ·Exhibits under Item 9.01: Financial Statements and Exhibits (contents NOT_DISCLOSED)
• ·Quantitative Data Extraction: Transaction Value NOT_DISCLOSED; Share Count NOT_DISCLOSED; Percentage Changes NOT_DISCLOSED; Financial Metrics NOT_DISCLOSED

18-12-2025

Shift4 Payments, Inc. filed an 8-K on December 18, 2025, reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 5.02 (Departure/Election of Directors/Officers or Compensatory Arrangements). No specific details on the agreement, personnel changes, or financial terms are disclosed in the provided summary. This multi-item filing indicates material events but lacks quantitative data for impact assessment.

• ·Multi-item 8-K filing: Items 1.01 and 5.02.
• ·Core events: Material definitive agreement and officer/director changes or comp arrangements.
• ·All transaction values, share counts, financial metrics: NOT_DISCLOSED.

18-12-2025

Enova International, Inc. filed an 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement under Item 1.01 and attaching exhibits under Item 9.01. Specific details of the agreement, transaction value, and financial impacts are NOT_DISCLOSED in the provided summary. This is a multi-item mandatory filing signaling a potentially significant event, but analysis is limited without full filing content.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED).
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED; timing compliance and strategic impact unknown.

18-12-2025

Camp4 Therapeutics Corp filed an 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement under Item 1.01, with exhibits under Item 9.01. No details on the agreement's nature, terms, or financial impact are disclosed in the provided summary. This is a multi-item mandatory disclosure of a material event.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Core event: Entry into unspecified Material Definitive Agreement
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED

18-12-2025

Fidelity D & D Bancorp Inc filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, individual, reason for change, or quantitative data are provided in the filing summary. This appears to be a routine disclosure with neutral implications pending further details.

• ·Item 5.02 indicates officer change, but key position (e.g., CEO, CFO), appointment/resignation status, reason, and timing are NOT_DISCLOSED
• ·Item 9.01 references financial statements/exhibits, but no details or numerical values extracted
• ·Quantitative data extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED
• ·No board meeting outcomes, succession details, or governance impacts specified

18-12-2025

CID Holdco, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, Regulation FD disclosure under Item 7.01, and exhibits under Item 9.01. No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; critical details NOT_DISCLOSED.

• ·Item 5.02 triggered: Indicates departure, election, or appointment of officers/directors, but specifics NOT_DISCLOSED.
• ·Item 7.01: Regulation FD disclosure filed, content NOT_DISCLOSED.
• ·Item 9.01: Financial statements/exhibits attached, details NOT_DISCLOSED.

18-12-2025

Virgin Galactic Holdings, Inc. filed a Form 8-K on December 18, 2025, reporting under Items 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing indicating a significant transaction involving agreements, financial obligations, and equity issuances. No specific details on transaction terms, values, or impacts are disclosed in the provided summary.

• ·Multi-item 8-K filing: Items 1.01, 2.03, 3.02, 9.01
• ·Core event involves material agreement, financial obligation, and unregistered equity sales (exact nature NOT_DISCLOSED)
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED

18-12-2025

Summit Hotel Properties, Inc. filed a Form 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). No specific transaction details, dollar values, or financial impacts are provided in the summary. Analysis is constrained by lack of explicit filing content beyond item descriptions.

• ·Multi-item 8-K filing reporting Items 1.01, 2.03, and 9.01
• ·Core event involves material definitive agreement creating financial obligation; all quantitative data (transaction value, share count, etc.) NOT_DISCLOSED
• ·Timing, compliance, and market reaction details NOT_DISCLOSED; voluntary/mandatory status tied to material event requirements

18-12-2025

NOCOPI Technologies Inc/MD/ filed an 8-K on December 18, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements of certain officers. No specific details on the officer's name, position (e.g., CEO, CFO), nature of change (appointment/resignation), reasons, or quantitative data are provided in the filing summary. Analysis is limited to the event type and timing, with all other elements NOT_DISCLOSED.

• ·Item 5.02 filing signals officer or director change, but key position, appointment/resignation status, and reasons NOT_DISCLOSED.
• ·No quantitative data (transaction value, share count, percentages, financial metrics) mentioned: all NOT_DISCLOSED.
• ·Neutral governance implications due to lack of details on internal/external hire, succession, or board impact.

18-12-2025

Tvardi Therapeutics, Inc. filed a Form 8-K on December 18, 2025 (AccNo: 0001104659-25-122615), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specific details on the officer's position, name, appointment/resignation status, reasons, or quantitative data (e.g., transaction values, share counts) are stated in the provided summary—all marked as NOT_DISCLOSED. Analysis is limited to filing facts, with no board outcomes, succession details, or market reactions disclosed.

• ·Item 5.02 disclosure for officer change, filed within SEC 4-business-day requirement
• ·No facts on key position (CEO/CFO/COO etc.), internal/external hire, or reasons provided
• ·No quantitative data (shares, values, percentages) or governance impacts extracted—ALL NOT_DISCLOSED

18-12-2025

F&M Bank Corp filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary.

• ·Item 5.02 indicates officer/director departure, election, appointment, or compensatory arrangement
• ·Filed timely on 2025-12-18 per SEC requirements (AccNo: 0001654954-25-014119)
• ·No names, positions, reasons, or financial metrics disclosed

18-12-2025

filed IPO Listing on December 18, 2025 - Global Offshore Services Ltd-$ (501848) - This is to inform that at the meeting of the Board of Directors of the Company held today, the following ...

• ·Filing Type: IPO Listing
• ·Priority: HIGH
• ·Global Offshore Services Ltd-$ (501848) - This is to inform that at the meeting of the Board of Directors of the Company held today, the following matters were considered and approved: 1] Subject to the approval of the Shareholders, Central Go

18-12-2025

filed Insolvency on December 18, 2025 - The Hi-Tech Gears Ltd (522073) - Updates on Corporate Insolvency Resolution Process

• ·Filing Type: Insolvency
• ·Priority: HIGH
• ·The Hi-Tech Gears Ltd (522073) - Updates on Corporate Insolvency Resolution Process

18-12-2025

Alight, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), alongside Regulation FD Disclosure (Item 7.01) and Financial Statements/Exhibits (Item 9.01). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited to disclosure of a leadership event without substantive content.

• ·Item 5.02 filing signals officer departure, election, appointment, or compensatory arrangements - specifics NOT_DISCLOSED
• ·Item 7.01 includes Regulation FD Disclosure - content NOT_DISCLOSED
• ·Item 9.01 lists exhibits - details NOT_DISCLOSED; no financial metrics or transaction values extracted

18-12-2025

filed IPO Listing on December 18, 2025 - Omnipotent Industries Ltd (543400) - Voting Result of the 1st 2025-26 Extra Ordinary General Meeting of the Company along with the Scrutinizer Repo...

• ·Filing Type: IPO Listing
• ·Priority: HIGH
• ·Omnipotent Industries Ltd (543400) - Voting Result of the 1st 2025-26 Extra Ordinary General Meeting of the Company along with the Scrutinizer Report thereon

18-12-2025

Brand Engagement Network Inc. filed a Form 8-K on 2025-12-18 reporting Items 1.01 (Material Definitive Agreement), 2.03 (Direct Financial Obligation), 3.02 (Unregistered Equity Sales), 8.01 (Other Events), and 9.01 (Exhibits). No transaction details, values, or impacts are disclosed in the summary. Full filing review required for assessment.

• ·Multi-item mandatory 8-K filing covering agreement, financial obligation, equity sales, and other events.
• ·Quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED.
• ·Timing compliance and core event details: NOT_DISCLOSED.

18-12-2025

BeOne Medicines Ltd. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specific details on the officer position, name, appointment/resignation status, or reasons are provided in the filing summary. Analysis is severely limited by absence of key facts, resulting in neutral investment implications.

• ·Item 5.02 disclosure confirms an officer or director change event.
• ·Filing date: December 18, 2025; AccNo: 0001651308-25-000151.
• ·No quantitative data (transaction values, shares, percentages, financial metrics) or qualitative details (position, reason, internal/external) disclosed.

18-12-2025

Performance Food Group Co filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers), along with Regulation FD Disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on the officer's position, appointment/resignation status, reason, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit filing content.

• ·Item 5.02 discloses officer change event, but key details (position, type, reason) NOT_DISCLOSED
• ·Item 7.01 includes Regulation FD Disclosure; content NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted; all NOT_DISCLOSED

18-12-2025

Kyverna Therapeutics, Inc. filed a Form 8-K on December 18, 2025 (AccNo: 0001213900-25-123033), disclosing entry into a material definitive agreement (Item 1.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are provided in the summary. This multi-item filing signals a potentially significant development but lacks data for directional assessment.

• ·Multi-item 8-K: Items 1.01, 8.01, 9.01 reported.
• ·Core event: Entry into Material Definitive Agreement (mandatory disclosure).
• ·All quantitative data (transaction value, shares, financial metrics): NOT_DISCLOSED.

18-12-2025

Vera Therapeutics, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on the individual, position, appointment/resignation, reasons, or quantitative data provided in the summary. Analysis limited to filing metadata.

• ·Item 5.02 filing indicates unspecified officer or director change.
• ·No names, positions (e.g., CEO/CFO), reasons, or timing details disclosed.
• ·Quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED.

18-12-2025

Udemy, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001193125-25-323401), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's nature, terms, or financial impact are disclosed in the provided summary. Analysis is limited to explicitly stated items; all transaction specifics are NOT_DISCLOSED.

• ·8-K reports Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: Entry into a Material Definitive Agreement; dollar value, share count, percentages, and financial metrics all NOT_DISCLOSED.
• ·No data on timing compliance, market reaction, related filings, or quantitative impacts; critical details missing.

18-12-2025

Avidity Biosciences, Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), other events under Item 8.01, and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit content.

• ·Item 5.02 discloses officer change; specifics NOT_DISCLOSED
• ·Filed 2025-12-18 per SEC requirements
• ·No numerical values, names, or reasons stated

18-12-2025

Cardlytics, Inc. filed an 8-K on December 18, 2025, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Regulation FD Disclosure in Item 7.01 and exhibits in Item 9.01. No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are disclosed in the provided filing summary. Analysis limited to filing structure; all key facts such as names, roles, and impacts are NOT_DISCLOSED.

• ·Item 5.02 discloses officer change event without specifics on key position (e.g., CEO/CFO) or nature (appointment/resignation)
• ·Item 7.01 includes Regulation FD Disclosure, potentially material non-public information
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED

18-12-2025

Aspen Aerogels Inc. filed an 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the agreement, transaction value, or disclosures are provided in the summary. Analysis is limited to filing structure due to lack of filing content.

• ·Multi-item 8-K filing: Items 1.01, 7.01, 9.01
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

18-12-2025

Helix Energy Solutions Group Inc filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, along with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on the officer's position, appointment/resignation, reasons, or quantitative data are provided in the summary. Analysis is limited to filing metadata, indicating a routine SEC disclosure without directional implications.

• ·Item 5.02: Departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements
• ·Item 7.01: Regulation FD disclosure
• ·Item 9.01: Financial statements and exhibits filed

18-12-2025

Cambium Networks Corp filed an 8-K on December 18, 2025, reporting a notice of delisting or failure to satisfy continued listing rules (Item 3.01) and departure of directors or certain officers (Item 5.02), with exhibits under Item 9.01. This is a multi-item mandatory disclosure signaling significant listing and governance issues. No financial metrics, transaction values, or detailed event descriptions are provided in the filing summary.

• ·Items reported: 3.01 (Delisting notice), 5.02 (Director/officer departures), 9.01 (Exhibits)
• ·Multi-item filing; mandatory disclosures
• ·Filed same day as event date (2025-12-18), likely within 4-business-day requirement

18-12-2025

filed Insolvency on December 18, 2025 - Alps Industries Ltd (530715) - Withdrawal of Intimation of Record Date for the purpose of Reduction and Consolidation of Equity Shares pursuant to ...

• ·Filing Type: Insolvency
• ·Priority: HIGH
• ·Alps Industries Ltd (530715) - Withdrawal of Intimation of Record Date for the purpose of Reduction and Consolidation of Equity Shares pursuant to the implementation of Resolution Plan

18-12-2025

MAXIMUS, INC. filed a Form 8-K on December 18, 2025, disclosing an event under Item 5.02 related to departure of directors or certain officers, election or appointment of directors/officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are provided in the filing summary. This represents a routine SEC disclosure with limited actionable information.

• ·Item 5.02 disclosure for officer/director changes or compensatory arrangements
• ·Filed timely on 2025-12-18 per SEC requirements
• ·All specifics (position, appointment/resignation, reasons) NOT_DISCLOSED

18-12-2025

MPLX LP filed an 8-K on December 18, 2025, under Item 5.02 disclosing a change involving departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions affected, individuals, reasons, or quantitative data are provided in the filing summary. Analysis limited to header information only.

• ·Item 5.02 filing indicates officer/director change or compensatory arrangement, but key details NOT_DISCLOSED.
• ·No information on appointment/resignation, internal/external hire, reasons, or timing provided.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

18-12-2025

Marathon Petroleum Corp filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on positions, individuals, reasons, or quantitative data are provided in the summary. Analysis is limited to filing structure and triggered items, with all key change details NOT_DISCLOSED.

• ·Item 5.02 triggered for officer/director departure, election, appointment, or compensatory arrangements
• ·Filed timely on 2025-12-18 per SEC 8-K requirements (within 4 business days)
• ·Items 8.01 and 9.01 indicate additional events and exhibits, but contents NOT_DISCLOSED

18-12-2025

Athira Pharma, Inc. filed a Form 8-K on 2025-12-18 (AccNo: 0001193125-25-323692) reporting Items 1.01 (Entry into Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, values, or financial metrics disclosed in the provided summary. Potential implications include strategic agreements and equity dilution, pending full filing review.

• ·Multi-item 8-K: Items 1.01, 3.02, 7.01, 8.01, 9.01.
• ·Core items suggest material agreement and unregistered equity sales.
• ·Filed on 2025-12-18; timing appears compliant (within 4 business days requirement, exact event timing NOT_DISCLOSED).

18-12-2025

Kalaris Therapeutics, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001193125-25-323706), reporting under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific transaction details, values, or financial metrics are disclosed in the provided summary. Analysis is limited to item descriptions, with all quantitative data NOT_DISCLOSED.

• ·Multi-item 8-K filing covering material agreement, equity sales, and other events.
• ·Core events: Material Definitive Agreement (Item 1.01) and Unregistered Sales of Equity Securities (Item 3.02).
• ·No dollar values, share counts, or financial impacts explicitly stated.

18-12-2025

GlobalTech Corp filed an 8-K on December 18, 2025 (AccNo: 0001477932-25-009036), announcing completion of an acquisition or disposition of assets (Item 2.01) and unregistered sales of equity securities (Item 3.02). Additional disclosures include Regulation FD information (Item 7.01) and financial statements/exhibits (Item 9.01). No specific deal structure, parties, valuation, or quantitative details are disclosed.

• ·Item 2.01 confirms completion of acquisition or asset disposition
• ·Item 3.02 discloses unregistered sales of equity securities
• ·Item 7.01 provides Regulation FD disclosure
• ·Item 9.01 includes financial statements and exhibits; details NOT_DISCLOSED

18-12-2025

Amaze Holdings, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the officer, position, appointment/resignation, or reasons are provided in the filing summary. Quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Item 5.02 indicates a leadership change event (officer departure, election, or appointment), but key details like position (e.g., CEO/CFO) and nature (resignation/appointment) are NOT_DISCLOSED.
• ·Includes Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01), suggesting potential additional material information.
• ·Filed timely per SEC 8-K requirements; sector NOT_DISCLOSED.

18-12-2025

PureCycle Technologies, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on position, individual, reason, or quantitative data are provided in the summary. Item 9.01 references financial statements and exhibits, but content is NOT_DISCLOSED.

• ·Item 5.02 filing indicates unspecified officer change, appointment, or compensatory arrangement.
• ·No names, positions (e.g., CEO/CFO), reasons (e.g., resignation/retirement), or timing details disclosed.
• ·Quantitative data extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

18-12-2025

Avantor, Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; critical details NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or appointment of certain officers; specifics NOT_DISCLOSED
• ·Item 7.01: Regulation FD Disclosure; content NOT_DISCLOSED
• ·Item 9.01: Financial Statements and Exhibits; details NOT_DISCLOSED

18-12-2025

Greenpro Capital Corp. filed a Form 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), with exhibits under Item 9.01. No specific transaction details, values, or financial impacts are disclosed in the provided summary. This multi-item filing signals potentially material developments, but analysis is limited without full filing content.

• ·Multi-item 8-K: Items 1.01, 3.02, 9.01 reported.
• ·Core events involve material agreement and unregistered equity sales; all quantitative data NOT_DISCLOSED.
• ·Filed same day as event; compliance with 4-business-day window presumed but unverified.

18-12-2025

Sprinklr, Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), along with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). Specific details on the officer position, nature of change (appointment/resignation), reasons, or quantitative data are NOT_DISCLOSED. Analysis limited to filing items; no facts on leadership impact or market reaction available.

• ·Item 5.02: Officer change event (details NOT_DISCLOSED)
• ·Item 7.01: Regulation FD disclosure (content NOT_DISCLOSED)
• ·Item 9.01: Financial statements and exhibits filed
• ·No quantitative data (shares, values, percentages: NOT_DISCLOSED)

18-12-2025

Interactive Strength, Inc. filed a Form 8-K on December 18, 2025, disclosing Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), and 8.01 (Other Events). This is a multi-item filing with no specific transaction details, dollar values, or quantitative data provided in the summary. Analysis limited to item descriptions; core event and impacts NOT_DISCLOSED.

• ·Multi-item 8-K: Items 1.01, 2.03, 3.02, 8.01 reported.
• ·Timing: Filed 2025-12-18; compliance with 4-business-day window NOT_DISCLOSED.
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.

18-12-2025

CION Investment Corp filed a Form 8-K on December 18, 2025, reporting Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event, but specific details on the agreement, obligation size, or impacts are NOT_DISCLOSED. Analysis is limited to item descriptions with no quantitative data provided.

• ·Multi-item 8-K: Items 1.01, 2.03, 9.01 reported
• ·Core event: Entry into material agreement and new financial obligation
• ·No transaction value, financial metrics, or strategic details disclosed

18-12-2025

Sonim Technologies Inc. filed an 8-K on 2025-12-18 disclosing entry into a material definitive agreement (Item 1.01), completion of an acquisition or asset disposition (Item 2.01), creation of financial obligations (Item 2.03), unregistered equity sales (Item 3.02), material modifications to security holder rights (Item 3.03), other events (Item 8.01), and exhibits (Item 9.01). No specific details on parties, deal structure, valuation, transaction value, share counts, or financial metrics are disclosed in the provided summary. This indicates a completed significant corporate transaction with potential equity and obligation implications.

• ·Multiple 8-K items triggered signaling completed M&A and related events
• ·Quantitative data including transaction value, share counts, percentages, and financial metrics: NOT_DISCLOSED
• ·Exhibits (Item 9.01) likely contain agreement details, but not summarized here

18-12-2025

LKQ Corp filed a multi-item Form 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), plus other events (Item 8.01) and exhibits (Item 9.01). No specific transaction details, dollar values, or financial metrics are disclosed in the provided summary. Analysis is limited to item descriptions, indicating a potentially significant corporate action.

• ·Multi-item mandatory 8-K filing covering material agreement and new financial obligations.
• ·Filed same day as event date, likely within 4-business-day requirement.
• ·Exhibits filed but contents not specified; all quantitative data NOT_DISCLOSED.

18-12-2025

Constellation Acquisition Corp I filed an 8-K on December 18, 2025 (AccNo: 0001213900-25-123069), reporting a Merger/Acquisition event under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific deal structure, parties, valuation, or quantitative details are disclosed in the provided filing summary. Analysis is limited to filing metadata; all key M&A elements are NOT_DISCLOSED.

• ·Event classified as Merger/Acquisition by filer.
• ·Items 7.01 and 9.01 suggest press release or exhibits with material non-public information.
• ·Sector NOT_DISCLOSED; no numerical data (e.g., transaction value, shares, percentages) extracted.

18-12-2025

Skkynet Cloud Systems, Inc. filed a Form 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement under Item 1.01, with exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Full filing review required for substantive analysis.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; core event is entry into a material agreement
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

18-12-2025

ENB Financial Corp filed a multi-item Form 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), officer/director changes or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details, transaction values, or quantitative impacts are provided in the summary. Analysis is limited due to lack of filing content.

• ·Multi-item 8-K filing covering material agreement, financial obligation, management changes, and Reg FD disclosure.
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.
• ·Timing and compliance with 4-business-day requirement cannot be assessed without full filing.

18-12-2025

Skillz Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details on the officer position, nature of change (appointment or resignation), reasons, or any quantitative data are NOT_DISCLOSED in the provided summary. No sector specified; analysis limited to filing metadata.

• ·Item 5.02 indicates officer or director change event, but key position, type (appointment/resignation), and reasons NOT_DISCLOSED.
• ·Item 9.01 references exhibits, but contents and any financial metrics NOT_DISCLOSED.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

18-12-2025

DIH HOLDING US, INC. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data are provided in the summary.

• ·Item 5.02 indicates officer change or compensatory arrangements; specifics NOT_DISCLOSED
• ·Filed timely per SEC requirements on 2025-12-18 (AccNo: 0001493152-25-028295)
• ·Sector NOT_DISCLOSED; no quantitative data (e.g., transaction values, share counts) extracted

18-12-2025

Otter Tail Corp filed an 8-K on 2025-12-18 disclosing an officer change under Item 5.02, with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on position, appointment/resignation, reason, or quantitative data are provided in the summary. Analysis limited to filing structure; all other facts NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or appointment of officers/directors; specifics NOT_DISCLOSED
• ·Item 7.01: Regulation FD disclosure, content NOT_DISCLOSED
• ·Item 9.01: Financial statements/exhibits filed, details NOT_DISCLOSED

18-12-2025

Syra Health Corp filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), along with Other Events (Item 8.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided filing summary. Analysis is limited to disclosure of the event without substantive content.

• ·Officer change event reported under SEC Item 5.02
• ·Additional Items 8.01 and 9.01 filed, details NOT_DISCLOSED
• ·No names, positions, reasons, or numerical data (e.g., shares, values) specified

18-12-2025

Cosmos Health Inc. filed an 8-K on December 18, 2025, under Items 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule) and 9.01 (Financial Statements and Exhibits), indicating a delisting event from US markets. No specific details on reasons, values, or impacts are disclosed in the provided summary. This is a material negative event signaling listing non-compliance.

• ·Items 3.01 and 9.01 reported in multi-item 8-K filing.
• ·Core event: Notice of delisting or failure to satisfy listing standards.
• ·No quantitative data (transaction value, shares, financial metrics) disclosed.

18-12-2025

ENVIRI Corp filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit information.

• ·Item 5.02 indicates officer-related change, but key position (e.g., CEO, CFO) is NOT_DISCLOSED
• ·No reasons, timing, or succession details stated
• ·Item 9.01 references exhibits, but contents/content NOT_DISCLOSED; sector not specified